AβPP-Selective BACE Inhibitors (ASBI): Novel Class of Therapeutic Agents for Alzheimer’s Disease

A systematic approach was used to identify AβPP-selective BACE inhibitors (ASBI) and to evaluate their in vivo ability to modulate AβPP processing selectively. We identified a bioflavonoid nutritional supplement as a molecular lead that acts as an ASBI in cell models, and show that increasing brain...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Descamps, Olivier, Spilman, Patricia, Zhang, Qiang, Libeu, Clare P., Poksay, Karen, Gorostiza, Olivia, Campagna, Jesus, Jagodzinska, Barbara, Bredesen, Dale E., John, Varghese
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2013
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3971881/
https://ncbi.nlm.nih.gov/pubmed/23948888
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JAD-130578
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk